FDA Inspection 604248 — Central Jersey Blood Center, Inc.

Central Jersey Blood Center, Inc. — FEI 2270821

The FDA completed an inspection of Central Jersey Blood Center, Inc. on Jul 10, 2009 in Shrewsbury, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 10, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Shrewsbury, NJ (United States)

Citations

IDCFRDescription
3621 CFR 606.40Suitable size, construction, etc.
4121 CFR 606.40(a)(1)Provide space for examination
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.